levonorgestrel has been researched along with Infections, Chlamydia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, K; Baeten, JM; Batting, J; Beksinska, M; Deese, J; Donnell, D; Edward, VA; Lind, M; Louw, CE; Mastro, TD; Morrison, C; Mugo, NR; Nanda, K; Onono, M; Palanee-Phillips, T; Philip, N; Rees, H; Smit, JA | 1 |
| Pisarska, MD; Schaub, AM; Wright, KN | 1 |
| Aronoff, DM; Bassis, CM; Bell, JD; Bergin, IL; Chai, D; Eastman, AJ; LeBar, W; Liechty, ER; Nyachieo, A; Oluoch, GO; Patton, DL; Young, VB | 1 |
| Cherpes, TL; Quispe Calla, NE; Vicetti Miguel, RD | 1 |
| Goler, N; Lee, JW; Merchant, M; Raine-Bennett, T; Sinclair, F | 1 |
| Bassis, CM; Bell, JD; Bergin, IL; Chai, D; LeBar, W; Liechty, ER; Young, VB | 1 |
| Creinin, MD; Eisenberg, DL; Keder, LM; Teal, SB; Turok, DK | 1 |
| Cherpes, TL; Fan, S; Gilmore, JR; Mei, A; Quispe Calla, NE; Vicetti Miguel, RD | 1 |
| Brabin, L; Hopkins, M; Humphris, G; O'Brien, K; Ozakinci, G; Roberts, SA; Thomas, G | 1 |
1 trial(s) available for levonorgestrel and Infections, Chlamydia
| Article | Year |
|---|---|
Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant.
Topics: Adolescent; Adult; Africa; Chlamydia Infections; Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Disease Susceptibility; Drug Implants; Female; Gonorrhea; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate; Prevalence; Young Adult | 2021 |
9 other study(ies) available for levonorgestrel and Infections, Chlamydia
| Article | Year |
|---|---|
Intrauterine Adhesions After Chlamydia Infection With a Levonorgestrel-Releasing Intrauterine Device in Place.
Topics: Adult; Chlamydia Infections; Diagnosis, Differential; Female; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Tissue Adhesions; Uterine Diseases | 2021 |
Impact of the Levonorgestrel-Releasing Intrauterine System on the Progression of Chlamydia trachomatis Infection to Pelvic Inflammatory Disease in a Baboon Model.
Topics: Animals; Antibodies, Bacterial; Cervix Uteri; Chlamydia Infections; Chlamydia trachomatis; Contraceptive Agents, Female; Cytokines; Disease Models, Animal; Disease Progression; Fallopian Tubes; Female; Intrauterine Devices; Levonorgestrel; Papio; Pelvic Inflammatory Disease; Sexually Transmitted Diseases, Bacterial; Vagina | 2018 |
Levonorgestrel and Female Genital Tract Immunity: Time for a Closer Look.
Topics: Animals; Chlamydia Infections; Chlamydia trachomatis; Female; Genitalia, Female; Humans; Levonorgestrel; Papio; Pelvic Inflammatory Disease | 2018 |
Reproductive health outcomes of insured adolescent and adult women who access oral levonorgestrel emergency contraception.
Topics: Adolescent; Adult; California; Chlamydia Infections; Contraception Behavior; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Drug Implants; Drug Prescriptions; Female; Gonorrhea; Humans; Insurance, Health; Intrauterine Devices; Levonorgestrel; Office Visits; Pregnancy; Pregnancy Rate; Reproductive Health; Retrospective Studies; Telephone; Young Adult | 2015 |
The levonorgestrel-releasing intrauterine system is associated with delayed endocervical clearance of Chlamydia trachomatis without alterations in vaginal microbiota.
Topics: Administration, Intravaginal; Animals; Bacteriological Techniques; Chlamydia Infections; Chlamydia trachomatis; Contraceptive Agents, Female; Disease Models, Animal; Drug Delivery Systems; Endometrium; Female; Levonorgestrel; Microbiota; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Papio; Time Factors; Vagina | 2015 |
A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement.
Topics: Adolescent; Adult; Chlamydia Infections; Contraceptive Agents, Female; Endometritis; Female; Gonorrhea; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pelvic Infection; Pelvic Inflammatory Disease; Prospective Studies; Randomized Controlled Trials as Topic; Sexually Transmitted Diseases; Time Factors; Young Adult | 2016 |
Dendritic cell function and pathogen-specific T cell immunity are inhibited in mice administered levonorgestrel prior to intranasal Chlamydia trachomatis infection.
Topics: Administration, Intranasal; Animals; Cell Proliferation; Chlamydia Infections; Chlamydia trachomatis; Dendritic Cells; Humans; Immunity; Levonorgestrel; Lung; Mice; T-Lymphocytes | 2016 |
Intrauterine devices: an effective alternative to oral hormonal contraception.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Anticoagulants; Breast Neoplasms; Chlamydia Infections; Contraception; Contraceptives, Oral, Combined; Dysmenorrhea; Endocarditis; Epilepsy; Female; Heart Valve Diseases; Humans; Infections; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Menstruation Disturbances; Pelvic Infection; Pregnancy; Pregnancy Complications; Pregnancy, Ectopic; Uterine Perforation | 2009 |
A qualitative study of pharmacists' views on offering chlamydia screening to women requesting Emergency Hormonal Contraception.
Topics: Attitude of Health Personnel; Chlamydia Infections; Community Pharmacy Services; Contraception, Postcoital; Contraceptives, Oral, Hormonal; Delivery of Health Care; England; Female; Humans; Levonorgestrel; Mass Screening; Pharmacists; Self Care | 2010 |